Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to ...
Pint Pharma to facilitate expansion of Phase 3 INSPIRE trial to Argentina, Chile, and Brazil in preparation for future studies of oral rigosertibNEWTOWN, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage …